Saliva Analysis After Low-level Laser Therapy Application on the Masseter Muscle Located Above Parotid Salivary Gland
Biochemistry and Volumetric Analysis of Biofluid Salivary, Correlating the Flow, pH and Buffer Capacity With and Without Stimulation of the Masseter Muscle, Before and After Low-level Laser Irradiation
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to obtain experimental data on the possible changes that saliva may suffer when brought to low-level laser therapy protocols for analgesia in the masseter muscle, because this be on the Parotid salivary gland.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 9, 2016
CompletedFirst Posted
Study publicly available on registry
August 29, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedAugust 29, 2016
August 1, 2016
2.6 years
August 9, 2016
August 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Increased salivary flow
Expect positive results of this research on the increased salivary flow , improved saliva buffer capacity as well as increased salivary pH enabling a better quality of life for patients.
24 months
Secondary Outcomes (1)
Improvement of the salivary pH
24 months
Other Outcomes (1)
Increase in saliva buffer capacity
24 months
Study Arms (4)
Infrared Laser
ACTIVE COMPARATORUsing a laser in the infrared wave spectrum (780 nm)
Red Laser
ACTIVE COMPARATORUsing laser red wave spectrum (662 nm)
Placebo
PLACEBO COMPARATORSimulation of treatment with the device switched off
Control
ACTIVE COMPARATORA scientific control group allows the experimental study of a variable at a time, and is a vital part of the scientific method. In a controlled experiment, two identical experiments are conducted. In one, the treatment - tested factor - is applied. In another - control - the tested factor is not applied For example, when testing a drug, it is important to carefully check the suspected drug effects are produced by the drug. Doctors can it with a double-blind study in a clinical trial: two ( statistically ) identical groups of patients are compared, one gets the drug and the other receives a placebo. Neither subjects nor investigators know which group receives the actual drug , which serves to prevent bias and isolating effects of such drugs.
Interventions
Supported by the physical phenomenon of stimulated emission postulated by Albert Einstein in 1916 the laser (light amplification by Stimulated Emission of Radiation) is a device consisting of solid source materials, liquid or gas that produces beams of light when excited by a source of energy. This bright feature is a particular type of electromagnetic radiation, which differs from that emitted by conventional incandescent sources. These are the effects attributable to LLLT analgesic, anti-inflammatory and biostimulates and has been widely used due to low power densities and wavelengths with a penetration capacity in tissues without the generation of photothermal effects, which makes its feasible use multiple applications in Health area.
A scientific control group allows the experimental study of a variable at a time, and is a vital part of the scientific method. In a controlled experiment, two identical experiments are conducted. In one, the treatment - tested factor - is applied. In another - control - the tested factor is not applied. For example, when testing a drug, it is important to carefully check the suspected drug effects are produced by the drug. Doctors can it with a double-blind study in a clinical trial: two (statistically) identical groups of patients are compared, one gets the drug and the other receives a placebo. Neither subjects nor investigators know which group receives the actual drug, which serves to prevent bias and isolating effects of such drugs.
Eligibility Criteria
You may qualify if:
- Have all dental organs
- Male volunteers
- Age between 18 and 30 years
- Body mass index between 18.5 and 25 (normal) .
You may not qualify if:
- Presence of problems that compromise the physiological activity of the masticatory system
- Neurological disorders
- Cerebral Palsy
- parafunctions :
- Sucking fingers
- Nail biting
- Nibble objects
- Bruxism
- Mouth breathing .
- Use of medication :
- Antihistamines
- Benzodiazepines
- Depressants of the central nervous system.
- Temporomandibular dysfunction:
- Clenching of the teeth
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leandro Júnio Masulo
São José dos Campos, São Paulo, 55, Brazil
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2016
First Posted
August 29, 2016
Study Start
January 1, 2014
Primary Completion
August 1, 2016
Study Completion
September 1, 2018
Last Updated
August 29, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will share